In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Vascular: The Now-Ready-For-Prime-Time Player

Executive Summary

Four years ago, lured into a mainstream cardiovascular business by the promise of drug-eluting stents, Abbott set about revamping its medical products business in an effort to create a device business that would rival its pharmaceutical business in financial returns. What was at first a niche strategy, aimed at bringing small, but interesting technologies to interventionalists, has become a more broad-based play that, company officials hope, will place them among the leaders in vascular devices.
Advertisement

Related Content

Abbott Ventures: Extending Horizons in Abbott's Device Pipeline
Abbott Ventures: Building A Venture Portfolio in Devices
From Guidant to Abbott: An Interview with John Capek
B. Braun's Bet on Balloons
An Open Market for Vascular Closure Devices
Carotid Stenting: Trials and Tribulations
TCT Highlights: Late Stent Thrombosis Controversy Continues
Ovalis' Reverse Spin
PCR's Pas de Deux
Abbott: Cracking the Cardiology Cartel

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV002332

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel